Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblasts

Mutation Research - Genetic Toxicology

Volumn 371, Issue 1-2, 1996, Pages 105-108

  DeLeve, Laurie D ^a,b,c  

^a Research Institute   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell, cultured; Dermatologic agent; Dinitrochlorobenzene; Sister chromatid exchange

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030569365     PISSN: 01651218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1218(96)90099-3     Document Type: Article

References (16)

1. Strobel R., Röhrborn G. Mutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE). Arch. Toxicol. 45:1980;307-314.
2. Summer K.H., Göggelmann W. 1-Chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium. Mutation Res. 77:1980;91-93.
3. Black H.S., Castrow F.F. II, Gerguis J. The mutagenicity of dinitrochlorobenzene. Arch. Dermatol. 121:1985;348-349.
4. Wilkerson M.G., Connor T.H., Wilkin J.K. Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants. Arch. Dermatol. 124:1988;396-398.
5. Shimizu M., Yasui Y., Matsumoto N. Structural specificity of aromatic compounds with special reference to mutagenic activity in Salmonella typhimurium - a series of chloro- or fluoro-nitrobenzene derivatives. Mutation Res. 116:1983;217-238.
6. Stricker R.B., Elswood B.F., Abrams D.I. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS. Immunol. Lett. 29:1991;191-196.
7. Stricker R.B., Zhu Y.S., Elswood B.F., Dumlao C., Van Elk J., Berger T.G., Tappero J., Epstein W.L., Kiprov D.D. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Immunol. Lett. 36:1993;1-6.
8. Stricker R.B., Elswood B.F., Goldberg B., Dumlao C., Van Elk J., Henry J., Winger E.E., Epstein W.L. Clinical and immunologic evaluation of HIV-infected patients with dinitrochlorobenzene. J. Am. Acad. Dermatol. 31:1994;462-466.
9. Stricker R.B., Goldberg B., Epstein W.L. Immunological changes in patient with systemicic lupus erythematosus with topical dinitrochlorobenzene. Lancet. 345:1995;1505-1506.
10. Stricker R.B., Goldberg B. Safety of topical dinitrochlorobenzene. Lancet. 346:1995;1293.
11. Weisburger E.K., Russfield A.B., Homburger F., Weisburger J.H., Roger E., Van Dongen C.G., Chu K.C. Testing of twenty one environmental aromatic amines or derivatives for long term toxicity and carcinogenicity. J. Environ. Pathol. Toxicol. 2:1978;325-356.
12. Galloway S.M., Deasy D.A., Bean C.L., Kraynak A.R., Armstrong M.J., Bradley M.O. Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity. Mutation Res. 189:1987;15-25.
13. Tucker J.D., Auletta A., Cimino M.C., Dearfield K.L., Jacobson-Kram D., Tice R.R., Carrano A.V. Sister-chromatid exchange: second report of the Gene-Tox program. Mutation Res. 297:1993;101-180.
14. Abe S., Sasaki M. Sister chromatid exchange as an index of mutagenesis and/or carcinogenesis. Sandberg A.A. Sister chromatid exchange. 1982;461-514 Alan R. Liss, Inc. New York.
15. Feldmann R.J., Maibach H.I. Absorption of some organic compounds through the skin in man. J. Invest. Dermatol. 54:1970;399-404.
16. Shapiro J. Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol. Clin. 11:1993;611-617.